Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 61-67, January 2008

Dopamine Transporter Genotype Conveys Familial Risk of Attention-Deficit/Hyperactivity Disorder Through Striatal Activation

Drs. Durston, Mulder, Ziermans, Vessaz, and Van Engeland are with the Department of Child and Adolescent Psychiatry, Rudolf Magnus Institute for Neurosciences; Drs. Casey and Durston are with the Sackler Institute for Developmental Psychobiology; and Dr. Fossella is with Mount Sinai Hospital, New York

Accepted 31 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by a Dutch Science Foundation VENI grant to Dr. Durston. The authors gratefully acknowledge all of the families who participated in this study; Nick Ramsey, Arjan van der Schaaf, and Bert Heesakkers for technical support; Bas Neggers, Erno Hermans, Matthijs Vink, and Martijn van der Heuvel for SPM2 support; and the clinical team at the Disruptive Disorders Clinic for their help in subject recruitment.

 Clinical trial registration information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00143832.

 Disclosure: The authors report no conflicts of interest

PII: S0890-8567(09)62085-2

doi:10.1097/chi.0b013e31815a5f17

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 61-67, January 2008

Article Tools

* Image Usage & Resolution